Real-time enrollment status for this recurrent oligodendroglioma clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 5:38 PM UTC
| NCT Number | NCT06254326 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Oligodendroglioma |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | May 27, 2026 (May 27, 2026) |
As of July 20, 2026: Clinical trial NCT06254326 is currently recruiting participants. This phase1 study for recurrent oligodendroglioma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06254326 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06254326 was last updated May 27, 2026 (May 27, 2026). HelloStudys verifies this status automatically.